| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Hatta, A Duni, C G Ng, N Lin, M Marhani, S Das, N J Nik Ruzyane. Effects of Selective Serotonin Reuptake Inhibitors (SSRIs) therapy on the female sexual response cycle of women with major depression. La Clinica terapeutica. vol 164. issue 1. 2014-10-09. PMID:23455735. |
this study aimed to examine the components of the female sexual response cycle (src) of women with major depression treated with selective serotonin reuptake inhibitors. |
2014-10-09 |
2023-08-12 |
Not clear |
| Andrea Iaboni, Alastair J Flin. The complex interplay of depression and falls in older adults: a clinical review. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 21. issue 5. 2014-10-09. PMID:23570891. |
the management of depression in fall-prone individuals is challenging, since antidepressant medications can increase the risk of falls, selective serotonin reuptake inhibitors may increase the risk of fragility fractures, and data are lacking about the effect of fall rehabilitation programs on clinically significant depression. |
2014-10-09 |
2023-08-12 |
Not clear |
| Waldemar Jałocha, Ewa Walecka-Kapica, Karolina Tomaszewska-Warda, Jan Chojnacki, Grazyna Klupińsk. [The effect of fluoxetine and tianeptine on emotional and eating disorders in postmenopausal women]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. vol 37. issue 217. 2014-10-02. PMID:25154197. |
fluoxetine -selective serotonin reuptake inhibitor (ssri) is used in the treatment of obesity and depression. |
2014-10-02 |
2023-08-13 |
Not clear |
| Raphaelle Mottolese, Jérôme Redouté, Nicolas Costes, Didier Le Bars, Angela Sirig. Switching brain serotonin with oxytocin. Proceedings of the National Academy of Sciences of the United States of America. vol 111. issue 23. 2014-09-30. PMID:24912179. |
serotonin (5-ht) and oxytocin (oxt) are two neuromodulators involved in human affect and sociality and in disorders like depression and autism. |
2014-09-30 |
2023-08-13 |
human |
| B Alevizos, E Alevizos, A Leonardou, I Zerva. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study. Psychiatrike = Psychiatriki. vol 23. issue 2. 2014-09-29. PMID:22796912. |
since it has been shown that low lithium levels increase serotonin turnover and enhance serotonin neurotransmission, we thought it of interest to assess the efficacy of low dosage lithium augmentation for patients with resistant depression. |
2014-09-29 |
2023-08-12 |
Not clear |
| Liming Shao, Wei Li, Qiong Xie, Hong Yi. Triple reuptake inhibitors: a patent review (2006 - 2012). Expert opinion on therapeutic patents. vol 24. issue 2. 2014-09-29. PMID:24289044. |
the dysfunctions of three very important monoamine neurotransmitters, serotonin (5-ht), norepinephrine (ne) and dopamine (da), are associated with some of important cns diseases such as depression; developing the triple reuptake inhibitors (tris) that can rebalance 5-ht, ne and da through the inhibition of the monoamine reuptake transporters will lead to a more effective and safer antidepressant. |
2014-09-29 |
2023-08-12 |
Not clear |
| Weihai Chen, Qi Zhang, Wenxin Su, Haorong Zhang, Yu Yang, Jing Qiao, Nan Sui, Ming L. Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats. Pharmacology, biochemistry, and behavior. vol 117. 2014-09-25. PMID:24321440. |
given the known roles of serotonin (5-ht) in emotion, motivation, social behavior, and major depression - and its known interaction with dopamine - it is likely that serotonin also plays a crucial role in this behavior. |
2014-09-25 |
2023-08-12 |
rat |
| K Sakata, S M Duk. Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus. Neuroscience. vol 260. 2014-09-25. PMID:24345476. |
monoamine systems (serotonin, dopamine, and noradrenaline) are suggested to be involved in depression and schizophrenia since many of the current antidepressants and antipsychotics increase the brain levels of monoamines and/or act on monoamine receptors. |
2014-09-25 |
2023-08-12 |
mouse |
| Zhao-Cai Jiang, Wei-Jing Qi, Jin-Yan Wang, Fei Lu. Chronic administration of 5-HT1A receptor agonist relieves depression and depression-induced hypoalgesia. TheScientificWorldJournal. vol 2014. 2014-09-25. PMID:24592167. |
previous studies have shown that depressed patients as well as animal models of depression exhibit decreased sensitivity to evoked pain stimuli, and serotonin is indicated to be involved in depression-induced hypoalgesia. |
2014-09-25 |
2023-08-12 |
rat |
| Florence Gressier, Pierre Ellul, Céline Dutech, Abd El Kader Ait Tayeb, Joel Monfort, Emmanuelle Corruble, Laurent Becquemont, Patrick Hardy, Céline Verstuyf. Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression. The American journal of psychiatry. vol 171. issue 8. 2014-09-23. PMID:25082493. |
serotonin toxicity in a cyp2d6 poor metabolizer, initially diagnosed as a drug-resistant major depression. |
2014-09-23 |
2023-08-13 |
Not clear |
| Benjamin A Samuels, E David Leonardo, Alex Dranovsky, Amanda Williams, Erik Wong, Addie May I Nesbitt, Richard D McCurdy, Rene Hen, Mark Alte. Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors. PloS one. vol 9. issue 1. 2014-09-18. PMID:24465494. |
selective serotonin reuptake inhibitors (ssris) such as fluoxetine are the most common form of medication treatment for major depression. |
2014-09-18 |
2023-08-12 |
Not clear |
| Kevin M Wood, Anisa Zeqja, H Frederik Nijhout, Michael C Reed, Janet Best, Parastoo Hashem. Voltammetric and mathematical evidence for dual transport mediation of serotonin clearance in vivo. Journal of neurochemistry. vol 130. issue 3. 2014-09-16. PMID:24702305. |
understanding serotonin neurochemistry is important for improving treatments for neuropsychiatric disorders such as depression. |
2014-09-16 |
2023-08-13 |
mouse |
| S Aishwarya, Soundravally Rajendiren, Shivanand Kattimani, Pooja Dhiman, S Haritha, P H Ananthanarayana. Homocysteine and serotonin: association with postpartum depression. Asian journal of psychiatry. vol 6. issue 6. 2014-09-12. PMID:24309856. |
homocysteine and serotonin: association with postpartum depression. |
2014-09-12 |
2023-08-12 |
Not clear |
| S Aishwarya, Soundravally Rajendiren, Shivanand Kattimani, Pooja Dhiman, S Haritha, P H Ananthanarayana. Homocysteine and serotonin: association with postpartum depression. Asian journal of psychiatry. vol 6. issue 6. 2014-09-12. PMID:24309856. |
also, there was a significant negative correlation between serum homocysteine and serotonin levels in the postpartum depression group with a significant negative correlation between homocysteine and serotonin. |
2014-09-12 |
2023-08-12 |
Not clear |
| S Aishwarya, Soundravally Rajendiren, Shivanand Kattimani, Pooja Dhiman, S Haritha, P H Ananthanarayana. Homocysteine and serotonin: association with postpartum depression. Asian journal of psychiatry. vol 6. issue 6. 2014-09-12. PMID:24309856. |
our study also shows that homocysteinemia is associated with ppd whether at the first week or sixth week, while low serum serotonin may play a role in depression during the first week, but may not have a role in depression status at the sixth week. |
2014-09-12 |
2023-08-12 |
Not clear |
| Chaokun Li, Linlin Shan, Xinjuan Li, Linyu Wei, Dongliang L. Mifepristone modulates serotonin transporter function. Neural regeneration research. vol 9. issue 6. 2014-09-10. PMID:25206868. |
regulating serotonin expression can be used to treat psychotic depression. |
2014-09-10 |
2023-08-13 |
human |
| Chaokun Li, Linlin Shan, Xinjuan Li, Linyu Wei, Dongliang L. Mifepristone modulates serotonin transporter function. Neural regeneration research. vol 9. issue 6. 2014-09-10. PMID:25206868. |
our results show that mifepristone attenuates serotonin transporter activity by directly inhibiting the serotonin transporter, and suggests that the serotonin transporter is a pharmacological target of mifepristone for the treatment of psychotic depression. |
2014-09-10 |
2023-08-13 |
human |
| Sarah E MacIsaac, André F Carvalho, Danielle S Cha, Rodrigo B Mansur, Roger S McIntyr. The mechanism, efficacy, and tolerability profile of agomelatine. Expert opinion on pharmacotherapy. vol 15. issue 2. 2014-09-05. PMID:24328686. |
agomelatine is a novel antidepressant that acts as a melatonin mt1 and mt2 receptor agonist and serotonin 5-ht2c receptor antagonist, putatively reversing circadian rhythm disruption in major depressive disorder (mdd) and promoting dendritic neurogenesis in animal models of depression. |
2014-09-05 |
2023-08-12 |
Not clear |
| Y-S Ding, M Naganawa, J-D Gallezot, N Nabulsi, S-F Lin, J Ropchan, D Weinzimmer, T J McCarthy, R E Carson, Y Huang, M Laruell. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD. NeuroImage. vol 86. 2014-09-03. PMID:23933039. |
clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: implications on treatment of depression and adhd. |
2014-09-03 |
2023-08-12 |
monkey |
| Y-S Ding, M Naganawa, J-D Gallezot, N Nabulsi, S-F Lin, J Ropchan, D Weinzimmer, T J McCarthy, R E Carson, Y Huang, M Laruell. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD. NeuroImage. vol 86. 2014-09-03. PMID:23933039. |
atomoxetine (atx), a drug for treatment of depression and adhd, has a high affinity for the norepinephrine transporter (net); however, our previous study showed it had a blocking effect similar to fluoxetine on binding of [(11)c]dasb, a selective serotonin transporter (sert) ligand. |
2014-09-03 |
2023-08-12 |
monkey |